SSX1, SSX family member 1, 6756

N. diseases: 39; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 Biomarker disease LHGDN Biphasic synovial sarcoma expressed the SYT-SSX1 fusion transcript, whereas the monophasic subtype expressed the SYT-SSX2 fusion transcript. 15735574 2005
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 Biomarker disease BEFREE The detection of SYT-SSX1/2 fusion transcripts by RT-PCR is a valuable diagnostic marker of synovial sarcoma which can be used for the reclassification of cases whose diagnosis is difficult by routine methods. 15735574 2005
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 AlteredExpression disease BEFREE This is in contrast to the association between the SYT-SSX1 fusion protein expression and poorer prognosis in soft tissue synovial sarcomas. 15879502 2005
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 GeneticVariation disease BEFREE With this method, 27 tumors (9 synovial sarcomas and 18 nonsynovial sarcomas) were studied and showed SYT-SSX1 rearrangement in 6 cases and SYT-SSX2 in 3 cases. 15747098 2005
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 AlteredExpression disease BEFREE Previous studies have shown that SYT-SSX1 is the most common SYT-SSX fusion transcript in biphasic synovial sarcomas of the limbs. 15140553 2004
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 Biomarker disease BEFREE A poorly differentiated synovial sarcoma (SYT/SSX1) expresses neuroectodermal markers: a xenografts and in vitro culture study. 15163010 2004
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 Biomarker disease BEFREE Are there geographical differences in the frequency of SYT-SSX1 and SYT-SSX2 chimeric transcripts in synovial sarcoma? 15350633 2004
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 GeneticVariation disease BEFREE Synovial sarcomas (SS) consistently show a characteristic chromosomal translocation, t(X;18)(p11;q11), which usually leads to the formation of 2 chimeric fusion transcripts, SYT-SSX1 and -SSX2. 15069540 2004
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 Biomarker disease BEFREE A novel fusion gene, SS18L1/SSX1, in synovial sarcoma. 12696068 2003
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 Biomarker disease BEFREE This study was designed to evaluate the utility of a real-time reverse transcriptase-polymerase chain reaction (RT-PCR) assay to detect and distinguish SYT-SSX1 and SYT-SSX2 fusions in fresh and archival specimens of synovial sarcoma in pediatric patients seen at St. Jude Children's Research Hospital. 12469233 2003
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 Biomarker disease BEFREE Two homologues of the SSX gene (ie, SSX1 and SSX2) are involved in the vast majority of SS and the SYT-SSX1 type of fusion has been associated with inferior clinical outcome. 12707378 2003
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 GeneticVariation disease LHGDN The three fusion genes that have been detected thus far, SS18/SSX1, SS18/SSX2, and SS18/SSX4, account for more than 95% of the synovial sarcomas. 12696068 2003
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 Biomarker disease LHGDN It has been anticipated that the individual synovial sarcoma carries only one of these variants, however, in this study we demonstrated that SYT-SSX1 and SYT-SSX2 co-exist in a significant proportion of the cases. 12037676 2002
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 AlteredExpression disease BEFREE In the present investigation, we describe a new SS case that was previously shown to be negative for SYT/SSX1 and SYT/SSX2 expression by conventional reverse transcription polymerase chain reaction (RT-PCR) methods. 12065783 2002
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 AlteredExpression disease BEFREE The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery. 12173050 2002
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 Biomarker disease BEFREE Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas. 12037676 2002
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 GeneticVariation disease BEFREE This study was performed to analyze the expression of MAGE by immunohistochemistry with mAb 57B in 25 synovial sarcomas (12 monophasic, 13 biphasic), which were typed for the t(X;18)-derived fusion transcript by reverse transcriptase polymerase chain reaction (19 SYT-SSX1, 6 SYT-SSX2). 11957149 2002
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 GeneticVariation disease BEFREE As a result of the synovial sarcoma associated t(X;18) translocation, the human SYT gene on chromosome 18 is fused to either the SSX1 or the SSX2 gene on the X chromosome. 11423977 2001
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 Biomarker disease BEFREE Furthermore, association of SYT-SSX1 with the chromatin remodeling factor hBRM/hSNF2 alpha, which regulates transcription, was demonstrated in both SYT-SSX1-expressing 3Y1 cells and in the human synovial sarcoma cell line HS-SY-II. 11274403 2001
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 GeneticVariation disease BEFREE Synovial sarcomas (SS) are characterized by a chromosomal translocation t(X;18)(p11.2;q11.2) which usually fuses the SYT gene from chromosome 18 to SSX1 or SSX2 genes on chromosome X. 10879732 2000
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 GeneticVariation disease BEFREE In the three cases, a reverse transcription-polymerase chain reaction (RT-PCR) using ribonucleic acid extracted from formalin-fixed, paraffin-embedded tissues detected SYT-SSX1 fusion gene transcripts resulting from translocation t(X;18)(p11.2;q11.2), which is specific for synovial sarcoma. 11107054 2000
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 GeneticVariation disease BEFREE To address the relationship between the different cellular components found in synovial sarcoma, we deduced the presence of the synovial sarcoma-specific der(X)t(X;18)(p11.2;q11.2), and involvement of the SSX1 gene in both the epithelial/glandular and spindle cell components of 3 biphasic synovial sarcomas with wide ranging proportions of each of the 2 elements. 10404078 1999
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 GeneticVariation disease BEFREE Dual colour fluorescence in situ hybridization to paraffin-embedded samples to deduce the presence of the der(X)t(X;18)(p11.2;q11.2) and involvement of either the SSX1 or SSX2 gene: a diagnostic and prognostic aid for synovial sarcoma. 10398111 1999
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 GeneticVariation disease BEFREE The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome. 10397263 1999
CUI: C0039101
Disease: synovial sarcoma
synovial sarcoma
0.700 GeneticVariation disease BEFREE The t(X;18)(p11.2;q11.2) (SYT/SSX1 or SSX2) is represented in more than 95% of synovial sarcoma. 10565298 1999